Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

CDK5 antibody

The Mouse Monoclonal anti-CDK5 antibody has been validated for WB and IHC (fro). It is suitable to detect CDK5 in samples from Human, Mouse and Rat. There is 1 publication available.
Catalog No. ABIN782438

Quick Overview for CDK5 antibody (ABIN782438)

Target

See all CDK5 Antibodies
CDK5 (Cyclin-Dependent Kinase 5 (CDK5))

Reactivity

  • 128
  • 98
  • 98
  • 16
  • 14
  • 14
  • 12
  • 12
  • 11
  • 11
  • 9
  • 8
  • 5
  • 4
  • 3
  • 3
  • 3
  • 1
  • 1
  • 1
  • 1
Human, Mouse, Rat

Host

  • 115
  • 32
Mouse

Clonality

  • 115
  • 32
Monoclonal

Conjugate

  • 83
  • 9
  • 8
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This CDK5 antibody is un-conjugated

Application

  • 133
  • 43
  • 41
  • 39
  • 39
  • 33
  • 23
  • 21
  • 19
  • 14
  • 10
  • 4
  • 3
  • 1
Western Blotting (WB), Immunohistochemistry (Frozen Sections) (IHC (fro))

Clone

1H3
  • Specificity

    Specific for the ~ 28 kDa Cdk5 protein in Western blots of Rat striatal lysate. The antibody shows no cross reactivity with the CDK5 cofactor p35 or its degradation product p25.

    Cross-Reactivity (Details)

    Species reactivity (tested):Human, Mouse, Rat.

    Purification

    Protein G Chromatography.

    Immunogen

    Purified Rat Cdk5.

    Isotype

    IgG
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    10 mM HEPES ( pH 7.5), 150 mM NaCl, 100 μg/mL BSA and 50 % Glycerol.

    Handling Advice

    Avoid repeated freezing and thawing.

    Storage

    -20 °C

    Storage Comment

    Store the antibody undiluted (in aliquots) at -20 °C.
  • Amin, Zheng, Bk, Shukla, Skuntz, Grant, Steiner, Bhaskar, Pant: "The interaction of Munc 18 (p67) with the p10 domain of p35 protects in vivo Cdk5/p35 activity from inhibition by TFP5, a peptide derived from p35." in: Molecular biology of the cell, Vol. 27, Issue 21, pp. 3221-3232, (2017) (PubMed).

  • Target

    CDK5 (Cyclin-Dependent Kinase 5 (CDK5))

    Alternative Name

    CDK5

    Background

    The neuronal protein kinase, Cdk5 has been implicated in a vast array of normal neuronal functions including regulation of neurotransmitter synthesis (Kansy J et al., 2004), the presynaptic vesicle cycle (Nguyen, C. & Bibb, JA 2003), neurotransmitter receptor trafficking and dopamine neurotransmission (Bibb, JA et al. 1999). At the same time Cdk5 has been implicated in a plethora of neurological and neuropsychiatric disorders including Alzheimer's, Parkinson's, Huntington's, epilepsy, schizophrenia, and drug addiction. Detection of Cdk5 in normal samples as well as tissue undergoing neurodegeneration may advance studies in these areas. Moreover, this antibody may allow more accurate postmortem evaluations of Cdk5 protein expression, and thus serve as a valuable new reagent for neuropathology.Synonyms: Cell division protein kinase 5, Cyclin-dependent kinase 5, PSSALRE, Serine/threonine-protein kinase PSSALRE, TPKII catalytic subunit, Tau protein kinase II catalytic subunit

    Gene ID

    140908

    NCBI Accession

    NP_543161

    UniProt

    Q03114

    Pathways

    Cell Division Cycle, Regulation of Muscle Cell Differentiation, Synaptic Membrane, Regulation of Cell Size, Skeletal Muscle Fiber Development, Synaptic Vesicle Exocytosis
You are here:
Chat with us!